Erlocip 150mg Tablet (Erlotinib)

Overview:
Erlocip 150mg Tablet is a tyrosine kinase inhibitor (TKI) containing Erlotinib. It is prescribed for patients with advanced non-small cell lung cancer (NSCLC) and locally advanced or metastatic pancreatic cancer. Erlotinib works by blocking signals that promote cancer cell proliferation.

Uses:

• Treatment of advanced or metastatic NSCLC with EGFR mutations.

• Management of locally advanced or metastatic pancreatic cancer, usually in combination with chemotherapy.

• Helps slow tumor growth and improve patient outcomes.

Dosage & Administration:

• Take exactly as prescribed by your oncologist.

• Typically administered once daily, at least 1 hour before or 2 hours after meals.

• Swallow tablets whole; do not crush or chew.

Precautions:

• Inform your doctor if you have liver, kidney, or heart problems, or a history of interstitial lung disease.

• Regular blood tests and skin monitoring are recommended during treatment.

• Possible side effects include rash, diarrhea, nausea, fatigue, loss of appetite, or shortness of breath.

• Avoid pregnancy during treatment and use effective contraception.

• Store in a cool, dry place, away from light and moisture.

Why Choose Erlocip 150mg Tablet?

• Clinically proven targeted therapy for NSCLC and pancreatic cancer

• Helps control tumor growth and disease progression

• Safe under medical supervision

• Widely available and reliable

Package Includes:

• Each pack contains 10 tablets of 150mg Erlocip (Erlotinib)